微生态制剂在抗幽门螺杆菌治疗中的作用

幽门螺杆菌(Hp)与多种疾病有关,尤其是胃肠道疾病,例如慢性胃炎、消化性溃疡、胃黏膜相关组织淋巴瘤、胃癌等。多种抗生素联合质子泵抑制剂是抗Hp治疗的主要方法,但由于抗生素耐药性的增加,导致标准抗Hp治疗对Hp根除率明显下降,且治疗过程中不良反应较多,复发率较高。微生态制剂的研发,为抗Hp治疗提供了新的思路,在提高根除率及减少药物不良反应方面优势显著。

Role of Probiotics in the Treatment of Helicobacter Pylori

H.pylori infection can lead to a variety of diseases especially gastrointestinal diseases,such as chronic gastritis,peptic ulcer,gastric mucosa organizations,lymphoma,stomach cancer,etc..The main treatment of H.pylori is combined proton pump inhibitor and multiple antibiotics,however,due to the increase of antibiotic resistance,eradication rate of H.pylori has decreased obviously,and there are a lot of adverse reactions,and the recurrence rate is high.Development of probiotics provides a new approach for H.pylori treatment,the use of probiotics in the field of H.pylori infection has great advantages in improving eradication rate and reducing the adverse drug reactions.